Determination of the Effect of Human Immunodeficiency Virus-1 and Placental Malaria Infections on Maternal Antimalarial Antibody Levels and Transfer in Pregnant Women

Mulonzia, Naomi Wangui (1997) Determination of the Effect of Human Immunodeficiency Virus-1 and Placental Malaria Infections on Maternal Antimalarial Antibody Levels and Transfer in Pregnant Women. Masters thesis, Kenyatta University.

[img] PDF (Determination of the Effect of Human Immunodeficiency Virus-1 and Placental Malaria Infections on Maternal Antimalarial Antibody Levels and Transfer in Pregnant Women)
Mulonzia, Naomi Wangui.pdf - Accepted Version
Restricted to Repository staff only

Download (48MB) | Request a copy

Abstract

Pregnant women are more susceptible to malaria infection than their non-pregnant counterparts. One of the hallmark of Plasmodium falciparum infection in pregnant women is the sequestration of malaria parasites in the placental intervillous space a phenomenon referred to as placental malaria. Placental malaria contributes to low birth weight infants and this is a single greatest risk factor for early infant morbidity and mortality. In tropical countries, in addition to malaria infection, Human immunodeficiecy virus-1 (HIV -1) has become another major public health issue. Although earlier studies did not find a significant interaction between malaria and HIV infections, recent epidemiological investigations suggest that there is a strong biological interaction between HIV - 1 and P. falciparum malaria infections during pregnancy. Some of the adverse outcomes caused by this co-infection include: increased incidence of maternal malaria, increased incidence of congenital malaria and increased neonatal mortality of infants born to mothers with placenta malaria and HIV -I co-infection. However, the immunological basis for the susceptibility of pregnant women to placental malaria and the adverse effect of malaria and HIV are not well understood. In addition immunoglobulin G (IgG) is known to be transplacentally transferred to the foetus during pregnancy and this is thought to provide protection to infants in the first few months of life. In the light of the crucial role of maternally transferred immunoglobulins and the recently identified biological link between placental malaria and HIV-1 infection in pregnancy, the effect of HlV-1 and placental malaria infections on maternal antibody levels and transfer was investigated. This study was carried out to determine if there is any alterations in the humoral immune responses of pregnant women with P. falciparum infection. Specifically this study was designed to determine i) the effect of parity on anti-malarial antibody levels, ii) if there are any differences in the maternal antibody levels in the presence or absence of placental malaria infection, iii) if placental malaria affects passive transfer of antibodies from mother to child and iv) ifHIV-I infection impairs the antibody levels to malaria in pregnant women. Paired maternal and cord plasma were used to determine the malaria-specific antibody levels in four groups of women namely, HIV and placental malaria positive, HIV and placental malaria negative, HIV negative and placental malaria positive, and HIV positive and placental malaria negative. The antibody levels were determined using standard enzyme-linked immunosorbent assay (ELISA). Peptides corresponding repeat regions of the circum sporozoite-protein (CSP) and liver stage antigen (LSA-l) were used as target antigens. The results showed that primigravidae had similar antibody levels to multigravidae. Mothers with placental malaria had higher concentration of total immunoglobulins (Ig), IgG, IgG 1 and IgG3 subclasses of anti-malarial antibodies than mothers with no placental malaria. In contrast to recent reports, placental malaria did not appear to reduce the levels of malaria specific IgG. However, IgG 1 antibodies seemed to be more efficiently transferred than IgG3 antibodies. Mothers with HIV -1 .infection had similar levels of antibodies when compared to those with no HIV -1 infection implying that HIV -1 did not impair malaria specific antibody levels. In mothers with both HIV -1 and placental malaria infections, although total Ig and IgG levels were not altered, IgG 1 levels were particularly lower when compared to the HIV -1 (-)/placental malaria (+) group. Hence the observed increased incidence of malaria infection in pregnant women with HIV -1 infection may not be related to anti-malarial antibody levels.

Item Type: Thesis (Masters)
Subjects: Q Science > QL Zoology
Q Science > QR Microbiology > QR355 Virology
R Medicine > RA Public aspects of medicine > RA0421 Public health. Hygiene. Preventive Medicine
Divisions: Africana
Depositing User: Tim Khabala
Date Deposited: 09 Jan 2018 09:09
Last Modified: 09 Jan 2018 09:09
URI: http://thesisbank.jhia.ac.ke/id/eprint/3064

Actions (login required)

View Item View Item